MSMGF - The Global Forum on MSM & HIV

Endorse the REPEAL Act!
 
DEADLINE: 5 PM EASTERN, TUESDAY, MAY 7
This year, Congresswoman Barbara Lee will reintroduce the REPEAL Act with bipartisan support. If passed, this act will be a key step towards ending unfair and unjust HIV criminalization laws in the United States by:
•    Working with state stakeholders (i.e., state attorneys general, state public health officials, people living with HIV, legal advocacy and service organizations) to review laws, policies and cases that impose criminal liability on people living with HIV;
•    Developing a set of best practices for the treatment of HIV in criminal and civil commitment cases;
•    Issuing guidance to states based on those best practices;
•    Monitoring whether/how states change policies consistent with that guidance.
To find out more about the REPEAL Act, please see this fact sheet.

Show your support for the REPEAL Act! List your organization as an endorser by filling out this form by COB May7, 2013.  Endorsements will continue to be open after the introduction of the bill.
________________________________________
REPEAL Act History
Last Congress, Congresswoman Barbara Lee (CA-13) introduced the Repeal Existing Policies that Encourage and Allow Legal HIV Discrimination Act, or REPEAL Act. The 2011 Repeal Act expressed the sense of Congress that federal and state laws, policies, and regulations regarding people living with HIV/AIDS should:
1.    Not place unique or additional burdens on such individuals solely as a result of their HIV status
2.    Demonstrate a public health-oriented, evidence-based, medically accurate, and contemporary understanding of HIV transmission, health implications, treatment, and the impact of punitive HIV-specific laws and policies on affected people, families, and communities.

It received the support of 41 Members of Congress and nearly 80 organizations.

Date/Time: May 7, 2013 (2:00 pm - 3:00 pm)

Faculty: Kevin Ard, MD, MPH, Brigham and Women’s Hospital.

Description: Health care providers now have an expanding number of effective HIV prevention tools at their fingertips, including behavioral and biomedical interventions. This session provides step by step guidance on how clinicians can be most effective at preventing new HIV infections in high-risk MSM and transgender patients. Included is a discussion of evidence-based High Impact HIV Prevention Programs as recommended by the CDC, and how best to optimize implementation of HIV prevention programs in patient centered medical homes (PCMH) and other primary care settings.

Meeting Description:

The fourth webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will look at the current situation regarding pre-exposure prophylaxis (PrEP) in Europe and the US.
We will discuss the ongoing IPERGAY study in France and the PROUD study in England, as well as reviewing progress in the NEXT-PrEP and demonstration studies in the US. It will also discuss the implications of the negative results of the recent VOICE trial. The presentations will be followed by a question and answer session with our expert speakers.

Questions can be submitted in advance to gus@nam.org.uk. The webinar will be 90 minutes long and chaired by Gus Cairns of NAM.
 

Combining the expertise of the
UCSF Center of Excellence for Transgender Health
and the
World Professional Association for Transgender Health.

The National Transgender Health Summit aims to provide a multidisciplinary program presenting cutting edge research in transgender health and evidence based clinical training curricula for healthcare providers of all backgrounds.

CEUs, CMEs, and UCSF Course Credit offered.
 

Oakland Marriott City Center
1001 Broadway
Oakland, CA 94607
Host Hotel Website  http://www.marriott.com/hotels/travel/oakdt-oakland-marriott-city-center/?toDate=5/18/13&groupCode=uocuoca&stop_mobi=yes&fromDate=5/16/13&app=resvlink

2013 NATIONAL TRANSGENDER HEALTH SUMMIT
• Check-in: Thu May 16, 2013
• Check-out: Sat May 18, 2013
• Special rate available until: Thu Apr 25, 2013
OAKLAND MARRIOTT CITY CENTERKing or Double Bedded Rooms $124 per night

For website registration issues, please contact Jeff Whitman at jeff@wpath.org

For all other inquiries, including volunteer opportunities, please contact Charlie DeVries at Charlie.DeVries@ucsf.edu
 

Webinar to be held on the 28th of May 12.00 – 13.30 UTC/GMT (14- 15.30 CET, 8-9.30 US-EDT), will focus on the latest research and practice on the use of antiretrovirals for treatment and the prevention of HIV infections. A panel of international experts will explore what we currentlyknow and don’t know about the science, how antiretrovirals can benefit individuals and the wider community, and the opportunities and challenges of implementing TasP at a programmatic level. The IAS interactive Webinar will give HIV professionals an opportunity to learn more about TasP and discuss the issues with our experts

Presentations
 
•    Science and Application: Overview of antiretroviral drugs used to prevent transmission of HIV          Prof. Kenneth Mayer-  (Professor, Harvard Medical School and Harvard School of Public Health; founder and Co-Chair and Medical Research Director of The Fenway Institute.)
•    Guidelines and new directions: WHO guidelines and the front-lines in treatment          Dr. Meg Doherty-  (Coordinator for Treatment and Care at the HIV/AIDS Department of the World Health Organization)
 
•    The two sides of TasP: Challenges and opportunities of scaling up Treatment as Prevention    Prof. Joep Lange-     (Professor of Medicine, Head of the Department of Global Health, at the Academic Medical Center (AMC), University of Amsterdam)
 
•    The right to be treated and the freedom to choose: Community perspectives on TasP Mr. Kenly Sikwese- (Veteran AIDS activist and treatment literacy campaigner from Zambia)